Fritextsökning
Innehållstyper
-
WuXi AppTec, UK Ltd
-
Novo Nordisk establishes new factory in Denmark
Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.
-
Medicon Valley Alliance
-
Joy at Egetis after positive CHMP opinion – ”The single most important milestone”
Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."
-
Truly Labs AB
-
Galderma
-
Aurevia
-
JMP Statistical Discovery
-
QPS Netherlands B.V
-
Prövning av pillervaccin mot covid-19 avbryts i USA
Det amerikanska hälsodepartementet har beordrat stopp för en statligt finansierad fas IIb-studie som skulle utvärdera ett potentiellt pillervaccin mot covid-19.
-
ZEISS Insights: Measurement of bone plates and screws
Get free access to technical paper.
-
ProPharma
-
EMA review confirms a risk of new cancer after CAR-T
CAR-T cancer therapies can, in rare cases, induce secondary cancers. The European Medicines Agency (EMA) now recognises this and requires a warning label to be ...
-
TECHNIA AB
-
Cytel Sweden
-
Zelmic
-
A+ Science AB
-
Meribel Pharma Solna
-
Webinar: Support Trial Patients Transitioning to the Commercial Space
Register for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs.
-
Mastering Urine Microscopy
On-demand Webinar: Microscopy in urinalysis.
-
Metabolon
-
KI-studie: Nässköljning kunde ge information om KOL
Förekomsten av ett visst protein i näsan kunde användas som underlag för bedömning av KOL, i en ny studie från forskare vid Karolinska institutet.
-
RegFile AB
-
Fast Optical Sectioning of Developing Organisms and Tissue Microstructures
ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.